Empagliflozin inhibits cardiac hypertrophy via a mechanism involving integrin signalling
Year: 2026
Type: article
Source: British Journal of Pharmacology
DOI: 10.1111/bph.70637
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Awards: G2619155243, G4549715336
OpenAlex ID: W7203887002
